Fundraising Fox

Fountain Therapeutics

San Francisco, US · Founded 2018 · Delaware corporation

fountainml.com ↗

Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates. Its lead programs include a topically applied small-molecule combination to reverse age- and weight-loss-associated skin atrophy and a small-molecule modulator to preserve lean tissue and muscle mass in sarcopenia and GLP agonist-induced atrophy.

BiotechHealthtechLongevity

Founders & leadership

Fountain Therapeutics was founded in 2018 by Thomas A. Rando, Thomas Rando, Joseph Rodgers, and Tom Cheung.

TA
Thomas A. RandoCo-founder
TR
Thomas RandoCo-founder
JR
Joseph RodgersCo-founder
TC
Tom CheungCo-founder
T
TsangChief Business Officer

Reported raises · per SEC filings

Form D private placements

$26.9M disclosed across 3 rounds · 2018–2021

▶$15.9MraisedDec 2021 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William GreeneExecutive Officer, Director
  • Thomas RandoExecutive Officer, Director
  • Ashish KhannaDirector
  • Alex MorganDirector
Offering amount
$15.9M
Amount sold
$15.9M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedFeb 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ashish KhannaDirector
  • Thomas RandoExecutive Officer, Director
  • John DimosExecutive Officer, Director
Offering amount
$6M
Amount sold
$6M
First sale
Feb 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedSep 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas A. RandoExecutive Officer, Director, Promoter
Offering amount
$5M
Amount sold
$5M
First sale
May 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Fountain Life14 shared keywordsFountain Life is a private preventive health membership service that uses AI-guided diagnostics, physician-led interpretation, and restorative therapeutics to detect issues early and create personalized plans focused on healthspan and longevity. It offers members always-on access to an integrated care team and an AI medical expert platform (Zori), delivered through clinics located across the United States.
Fountain5 shared keywordsFountain provides an applicant tracking system designed specifically for hiring hourly workers at scale. The platform helps recruiters manage hiring processes from application to first day of work across 75+ countries.

Companies competing with Fountain Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Fountain Therapeutics do?
Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates. Its lead programs include a topically applied small-molecule combination to reverse age- and weight-loss-associated skin atrophy and a small-molecule modulator to preserve lean tissue and muscle mass in sarcopenia and GLP agonist-induced atrophy.
Who founded Fountain Therapeutics?
Fountain Therapeutics was founded by Thomas A. Rando, Thomas Rando, Joseph Rodgers, Tom Cheung in 2018.
How much funding has Fountain Therapeutics raised?
Fountain Therapeutics has disclosed $26.9M raised across 3 rounds.
Where is Fountain Therapeutics headquartered?
Fountain Therapeutics is headquartered in San Francisco, US.